Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. (Q40477472)

20 September 2017

Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. (English)

1 reference

20 September 2017

0 references

0 references

Mohammed A Ayoub

2

0 references

Anne Eckert

object named as

Anne Eckert

7

0 references

author name string

Egemen Savaskan

1

1 reference

20 September 2017

Rivka Ravid

3

1 reference

20 September 2017

Debora Angeloni

4

1 reference

20 September 2017

Franco Fraschini

5

1 reference

20 September 2017

Fides Meier

6

1 reference

20 September 2017

Franz Müller-Spahn

8

1 reference

20 September 2017

Ralf Jockers

9

1 reference

20 September 2017

1 January 2005

1 reference

Journal of Pineal Research

20 September 2017

1 reference

20 September 2017

38

1 reference

20 September 2017

1

1 reference

20 September 2017

10-16

1 reference

Circadian rhythms: basic neurobiology and clinical applications

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Rhythmic transcription: the molecular basis of circadian melatonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Mammalian melatonin receptors: molecular biology and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Melatonin is a potent modulator of dopamine release in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

The chemistry of melatonin's interaction with reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

The melatonin receptor subtype MT2 is present in the human cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Localization of the melatonin-related receptor in the rodent brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Distribution of melatonin MT1 receptor immunoreactivity in human retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Pinealectomy but not melatonin supplementation affects the diurnal variations in 125I-melatonin binding sites in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Melatonin receptors in rat hippocampus: molecular and functional investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

The modulation of neuronal activity by melatonin: in vitro studies on mouse hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

Alterations in the circadian rhythm of salivary melatonin begin during middle-age

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2004.00169.X

10.1111/J.1600-079X.2004.00169.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference